These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39313447)

  • 21. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterizations of three adults with genetically confirmed spinal muscular atrophy: a case series.
    Setyaningrum CTS; Harahap ISK; Nurputra DK; Ar Rochmah M; Sadewa AH; Alkarani GH; Harahap NIF
    J Med Case Rep; 2022 Nov; 16(1):435. PubMed ID: 36376972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difficult path to diagnosis of the patient with spinal muscular atrophy.
    Bolaño Díaz CF; Morosini M; Chloca F; Mesa L; Jáuregui A; Pirra L; Vazquez G; Flores D; Dubrovsky A
    Arch Argent Pediatr; 2023 Apr; 121(2):e202102542. PubMed ID: 36287576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Room to improve: The diagnostic journey of Spinal Muscular Atrophy.
    Carter M; Tobin A; Coy L; McDonald D; Hennessy M; O'Rourke D
    Eur J Paediatr Neurol; 2023 Jan; 42():42-46. PubMed ID: 36525883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy.
    Dobelmann V; Roos A; Hentschel A; Della Marina A; Leo M; Schmitt LI; Maggi L; Schara-Schmidt U; Hagenacker T; Ruck T; Kölbel H
    J Neurol; 2024 Oct; 271(10):7000-7011. PubMed ID: 39240344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal Muscular Atrophy Type III Recognized After Delayed Recovery From Neuromuscular Blockade After an Orthognathic Surgery.
    Oda A; Oue K; Yoshida M
    J Craniofac Surg; 2023 Sep; 34(6):e580-e582. PubMed ID: 37253240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?
    Pera MC; Coratti G; Berti B; D'Amico A; Sframeli M; Albamonte E; de Sanctis R; Messina S; Catteruccia M; Brigati G; Antonaci L; Lucibello S; Bruno C; Sansone VA; Bertini E; Tiziano D; Pane M; Mercuri E
    PLoS One; 2020; 15(3):e0230677. PubMed ID: 32203538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.
    Karakaya M; Storbeck M; Strathmann EA; Delle Vedove A; Hölker I; Altmueller J; Naghiyeva L; Schmitz-Steinkrüger L; Vezyroglou K; Motameny S; Alawbathani S; Thiele H; Polat AI; Okur D; Boostani R; Karimiani EG; Wunderlich G; Ardicli D; Topaloglu H; Kirschner J; Schrank B; Maroofian R; Magnusson O; Yis U; Nürnberg P; Heller R; Wirth B
    Hum Mutat; 2018 Sep; 39(9):1284-1298. PubMed ID: 29858556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy: Observational study.
    Zhang Y; He J; Zhang Y; Li L; Tang X; Wang L; Guo J; Jin C; Tighe S; Zhang Y; Zhu Y; Zhu B
    Medicine (Baltimore); 2020 Jan; 99(3):e18809. PubMed ID: 32011487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Spinal muscular atrophy in childhood. Possibilities and limits of clinical and molecular genetic diagnosis].
    Zerres K; Rudnik-Schöneborn S; Röhrig D; Wirth B
    Monatsschr Kinderheilkd; 1993 Nov; 141(11):848-54. PubMed ID: 8283989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study.
    Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA
    Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
    Coratti G; Bovis F; Pera MC; Scoto M; Montes J; Pasternak A; Mayhew A; Muni-Lofra R; Duong T; Rohwer A; Dunaway Young S; Civitello M; Salmin F; Mizzoni I; Morando S; Pane M; Albamonte E; D'Amico A; Brolatti N; Sframeli M; Marini-Bettolo C; Sansone VA; Bruno C; Messina S; Bertini E; Baranello G; Day J; Darras BT; De Vivo DC; Hirano M; Muntoni F; Finkel R; Mercuri E;
    Eur J Neurol; 2024 Aug; 31(8):e16309. PubMed ID: 38656662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.
    Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ
    Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Mutation Analysis and Report of 12 Novel Mutations in a Cohort of Patients with Spinal Muscular Atrophy in Iran.
    Sharifi Z; Taheri M; Fallah MS; Abiri M; Golnabi F; Bagherian H; Zeinali R; Farahzadi H; Alborji M; Tehrani PG; Amini M; Asnavandi S; Hashemi M; Forouzesh F; Zeinali S
    J Mol Neurosci; 2021 Nov; 71(11):2281-2298. PubMed ID: 33481221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of spinal muscular atrophy-like patients by targeted resequencing.
    Hosokawa S; Kubo Y; Arakawa R; Takashima H; Saito K
    Brain Dev; 2020 Feb; 42(2):148-156. PubMed ID: 31734026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.
    Zerres K; Rudnik-Schöneborn S
    Arch Neurol; 1995 May; 52(5):518-23. PubMed ID: 7733848
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.